Cellectis and Lonza form biomanufacturing partnership
Lonza is to collaborate with France’s Cellectis SA for the development and commercialisation of a bioengineered cell line.
Lonza is to collaborate with France’s Cellectis SA for the development and commercialisation of a bioengineered cell line.
US-based CRO TKL Research has taken an equity position in proinnovera GmbH to expand its presence and capabilities in Europe.
CRL shareholder Jana Partners has said the attempt to buy WuXi PharmaTech is the “wrong path” and it will vote against the deal.
GlaxoSmithKline (GSK) has described media reports of an overall review of operations in Ireland as “completely inaccurate”, telling in-PharmaTechnologist that the exercise only covers the plant in Cork.
Becton Dickinson (BD) is launching what could be the world’s smallest pen needle designed for insulin delivery. Patients in the United States will be the first recipients as BD aim to head up a market worth roughly $174bn (€145bn).
Covance has opened a 20,000 sq ft biorepository facility in Greenfield Indiana, US for the long-term storage of clinical trial specimens.